# Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis

> **NCT01080079** · PHASE2 · COMPLETED · sponsor: **Nitric BioTherapeutics, Inc** · enrollment: 168 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** Terbinafine Hydrochloride
- **OTHER:** Purified Water

## Key facts

- **NCT ID:** NCT01080079
- **Lead sponsor:** Nitric BioTherapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-11
- **Final completion:** 2012-06
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2012-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01080079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01080079, "Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01080079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*